The number of people with susceptibility test result for rifampicin in Japan
Japan: The number of people with susceptibility test result for rifampicin was 4,343 in 2021. ▼ Falling
Latest (2021)
4,343
Change on year
down 12.1%
World rank
32nd
of 155 countries
All-time high
7,533
in 2017
All-time low
4,343
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Japan, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Japan is 4,343, measured in 2021. That is the lowest value across all 5 years on record.
The figure is down 12.1% on the previous year and down 42.3% over five years.
Japan ranks 32nd of 155 countries on this measure, in the top quarter.
The number of people with susceptibility test result for rifampicin in Japan, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 7,533 | — |
| 2018 | 7,249 | -3.8% |
| 2019 | 6,295 | -13.2% |
| 2020 | 4,942 | -21.5% |
| 2021 | 4,343 | -12.1% |
Japan compared with similar countries
- Japan's 4,343 is above the median for high income countries, which is 142, 30.6× the median. (61 countries reporting)
- Japan's 4,343 is above the median for East Asia & Pacific, which is 185, 23.5× the median. (28 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 7,026 | 6,295 | 7,533 | 3 |
| 2020s | 4,642 | 4,343 | 4,942 | 2 |
Countries ranked near Japan
- 29 Uzbekistan 4,929 compare
- 30 United States of America 4,814 compare
- 31 Romania 4,366 compare
- 33 Guinea 4,242 compare
- 34 Mexico 4,205 compare
- 35 Madagascar 4,142 compare
More health data for Japan
- Un projection of annual infant deaths, annual growth rate -2.73 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.2774 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,294 deaths per 1,000 people (2090)
- Number of infants who die before age 1 178 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.22 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0155 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.36 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Japan?
- The number of people with susceptibility test result for rifampicin in Japan was 4,343 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Japan?
- The highest recorded value was 7,533 in 2017.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Japan?
- The lowest recorded value was 4,343 in 2021.
- How does Japan rank for the number of people with susceptibility test result for rifampicin?
- Japan ranks 32nd out of 155 countries with data for 2021.
- Where does this Japan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).